This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
3/8/2022
Good day, and welcome to the Everts Q3 Investor Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Brian Campbell, Executive Vice President of Business Development. Please go ahead, sir.
Thank you, Justin. Good afternoon, everyone, and welcome to the Everts Technologies Conference Call for our fiscal 2022 third quarter, ended January 31, 2022. with Doug Moore, Everett's Chief Financial Officer, and myself, Brian Campbell. Please note that our financial press release and MD&A will be available on CDAR and on the company's website. Doug and I will comment on the financial results and then open the call to your questions. Turning now to Everett's results, I'll begin by providing a few highlights and then Doug will go into more detail. First off, I'm very pleased to report that sales for the third quarter totaled $120.6 million, an increase of $27.8 million, up 30% compared to $92.8 million for the third quarter last year. Our base is well diversified, with the top 10 customers accounting for approximately 43% of sales during the quarter and with no single customer over 10%. In fact, we had 113 customer orders of over $200,000. Gross margin in the quarter was 69.2 million, or 57.4% for the quarter, which is within our gross margin target range. Net earnings for the third quarter were 21.6 million, up 108% from last year and fully diluted earnings per share was $0.28. Evert's working capital was $157.3 million with $29.8 million in cash as at January 31, 2020-2022. The purchase order backlog at the end of February was a record high of $176 million and shipments during the month of February were $25 million. We attribute this very strong financial performance and robust combined shipments and purchase order backlog to the ongoing technical transition in the industry, channel and video services proliferation, increasing global demand for high-quality video anywhere, anytime, and specifically to the growing adoption of Everett's IP-based software-defined video networking solutions, Everett's IT and cloud solutions, our immersive 4K Ultra HD solutions, our state-of-the-art Dreamcatcher IP replay and live production suite, and Bravo Studios. Today, Everett's board of directors declared a dividend of $0.18 per share payable on or about March 24, 2022. I will now hand over to Doug Moore, EVIT's Chief Financial Officer, to cover our results in greater detail.
Thank you, Brian. Good afternoon, everyone. Looking at revenues, sales were $120.6 million in the third quarter of fiscal 2022, an increase of $27.8 million, or 30%, compared to $92.8 million in the third quarter of fiscal 2021. For the nine months ended January 31, 2022, sales were $324.9 million compared to $249.6 million in the same period last year. That represents an increase of approximately 30%. Looking at specific regions, the U.S.-Canadian region had sales for the quarter of $78.9 million, an increase of $22.6 million or 40% compared to $56.3 million in the same period last year. Sales in the U.S.-Canadian region were $221.5 million for the nine-month period ended January 31, 2022, compared to $159.1 million in the same period last year. That's an increase of $62.4 million, or 39%. The international region had sales for the quarter of $41.7 million, compared to $36.5 million last year, an increase of $5.2 million, or 14%. The international segment represented 35% of total sales this quarter, compared to 39% in the same period last year. Sales in the international region were $103.4 million for the nine months ended January 31, 2022, compared to $90.5 million in the same period last year. This represents an increase of $12.9 million, or 14%. Gross margin for the third quarter was approximately 57.4%, compared to 56%. in the third quarter last year and within our target range. Gross margin for the nine months ended January 31st was approximately 57.5% and also within the company's target range. For operating expenses, selling and administrative expenses were $16.0 million for the third quarter, an increase of $4.3 million from the same period last year. Selling and admin expenses as a percentage of revenue were approximately 13.3% as compared to 12.6% for the same period last year. For the nine months ended, January 31st, 2022, selling and administrative expenses were $44.7 million, an increase of $8.3 million compared to $36.4 million from the same period last year. For the nine months period, selling and administrative expenses as a percentage of revenue were approximately 13.8% compared to 14.6% for the same period last year. Turning to R&D, research and development expenses were 26.0 million for the third quarter, which represents a $4.6 million increase from the third quarter last year. R&D expenses as a percentage of revenue were approximately 21.5% over the period as compared to 23.1% for the same period last year. For the year, research and development expenses were $75.1 million, which represents an increase of $17.4 million over the same period last year. R&D expenses as a percentage of revenue were approximately 23.1% over the period, and that's consistent with the same period last year. Foreign exchange for the third quarter resulted in a gain of $1.7 million compared to a loss of 5.3 million in the same period last year. The current quarter gain was driven by an increase in the value of the U.S. dollar compared to Canadian between October 31st and January 31st. Foreign exchange for the nine-month period ended January 31st, resulted in a gain of 5.4 million as compared to a loss of 9.8 million in the same period last year. The nine-month gain is also driven by the increase in value of the U.S. dollar, but since April 30th, 2021. Turning to the discussion of liquidity of the company, cash as at January 31st, 2022 was $29.8 million as compared to $108.8 million as at April 30th, 2021. Working capital was $157.3 million as at January 31st compared to $214.5 million as at the end of April 30th, 2021. Looking now specifically at the cash flows for the quarter ended January 31st, The company generated cash from operations of $8.3 million, which is net of a $20.3 million change in non-cash working capital and current taxes. If the effects of the change in non-cash working capital and current taxes are excluded, the company generated $28.6 million cash from operations for the quarter. The company used cash from investing activities of $0.7 million for the third quarter ended January 31, 2022. which was principally driven by the acquisition of capital assets of $1.2 million. The company used cash from financing activities of $15.7 million, which was principally driven by dividends paid of $13.7 million. Finally, reviewing our CR capital position as at January 31, 2022, shares outstanding were approximately $76.2 million and options outstanding were approximately $5.4 million. Lastly, the weighted average shares outstanding were 76.3 million, and weighted average fully diluted shares were 76.5 million. That brings to a conclusion the reviewer financial results and the position for the third quarter. Finally, I would like to remind you that some of the statements presented today are forward-looking, subject to a number of risks and uncertainties, and we refer you to the risk factors described in the annual information form in the official reports filed with the Canadian Securities Commission. Brian, back to yourself.
Thank you, Doug. Justin, we're now ready to open the call to questions.
Thank you. If you would like to signal with questions, please press star 1 on your touchtone telephone. If you're joining us today using a speakerphone, please make sure your mute function is turned off to allow your signal to reach our equipment. Again, that will be star 1 if you would like to signal with questions. And our first question comes from Thanos Mastropoulos with BMO Capital Markets.
Hi, good afternoon. Brian, can you provide some color on the spending environment? I mean, obviously, you had a strong quarter. The backlog keeps increasing. Now, as we're kind of maybe exiting some of the lockdowns and the pandemic, are you seeing – an uptick in demand just from live events starting to pick up again or from, you know, previously shelved spending priorities kind of coming back. What do you see in that regard?
Thanks. So, thank you, Thanos. We are seeing very good, solid demand from our existing customer base and some new, but very good demand for Evert's next generation IP solutions or cloud-based solutions, especially within the North American U.S. environment.
Okay. And in terms of the logistical constraints that you've had, you know, over the last, I guess, throughout the pandemic, I mean, to what extent is that improving? I know that Canada-U.S. travel now is getting easier, but as far as... deploying internationally. What's that situation looking like?
So, yes, with Canada-U.S., the logistics are getting easier. We have done very well over the past two years working through the pandemic, the quarantine. So we have a significant number of our people on staff available to travel to the U.S. to customer sites to help them with their installations and commissioning of solutions as well. We continue to execute to the best of our ability remotely, but again, too, it's very helpful for many of these installs to have folks available for on-site commissioning. That does extend internationally as well, too. We have teams in geographic regions both in Asia Pacific and in Europe, delivering major installs as well, too. So it is more challenging dealing with the logistics of quarantining and testing of our people abroad, but that has been continuing. So we haven't seen a significant change internationally in those constraints.
Okay. I guess up until this point, it seems like you've been – doing well dealing with potential component charges, supply chain issues. Does that remain the case or to what extent is that impeding some of the growth you might have otherwise had?
I'll comment to that. The challenges associated with obtaining components and increased costs is consistent with the past many months now. I don't think That environment is expected to end in the immediate term. That is a bit of a fluid situation, but we are doing our best to mitigate the challenges associated with that. Our raw materials and our inventory as a whole has increased about 12 million just since the last quarter. We continue to stockpile inventory as much as possible, but there are certainly challenges in the environment remaining.
But it's fair to say that it's not been having all that material of a revenue impact to this point based on the mitigating actions you've taken.
So we have been able to and continue to ship. Okay.
And deliver at a near record quarterly revenue level.
Okay, great. Maybe one last one for me is how do we think about the OpEx trajectory as travel and trade shows start to pick up again?
So one thing I'll note is that the quarter is no – there's no government assistance programs that are included at this point anymore, so the quarter has no cost reductions associated with that. We did have a – if you do Q3 versus Q3, there is a $1.5 million increase in travel costs associated with increased selling. So I think that many of those components are starting to rebound to – consistent levels. So we're certainly back on the road more often, and those costs are going to go up in hand.
All right. Thanks, all. That's fun.
Thank you. And once again, if you would like to signal with questions, please press star 1 on your touchtone telephone. Again, star 1 if you would like to ask questions. And our next question will come from Robert Young with Canaccord Genuities.
Good evening. The $10 million contract you announced, I think it was March 1st, and I think you said that it was received the day before. So is that in the backlog figure that you published today, or would that be an additional $10 million on top?
That is included. So the backlog includes that order. So we received the order on actually February 28th. So that is before the close of the month ends.
And the increase in inventory you just mentioned, is that entirely due to supply chain and component stockpiling, or is there some staging or work in process for future opportunities? Is that a factor as well, or is it just supply chain?
Well, the most significant component is associated with raw materials. So we do have a record backlog that we need to purchase for. But We are doing our best to mitigate these challenges associated with the supply chain, so we are stockpiling, planning out further than we did, and quite frankly, just buying more inventory than we used to.
Okay, okay. The Studer manufacturing transition, I see that's complete. Does that have any impact on the financials? Does that have an impact on gross margins, or is there anything positive or negative you'd call out from that completion?
It's still in process. The transition and our ramping up of student manufacturing is a work in process. We're doing very well, and we don't expect it to alter our gross margins.
Okay. Last question. I know you've had business in Russia in the past and Eastern Europe, and so Is there any material exposure to that to call out?
In regards to sanctions, so we will most certainly comply with all government rules and requirements. Our revenues over the past three years have been on average less than 2%, so there's some fluidity to that, but it has not exceeded that amount.
Okay. Okay. is that Russia and Ukraine together? Is that just Russia?
That would be a combination.
Okay. And maybe the last question for me would just be, um, uh, on the OPEX, um, maybe continue Thanos question. Uh, so there's increased sales and marketing, but there was also a pretty strong jump in R and D. And so as we look forward, should we be thinking of Q3 as a baseline for going forward? Um, Just in absolute terms, like should we be thinking of, you know, a $22 million type of a net R&D number and, you know, $17 million sort of range of selling it in men or will it come down? There's been a lot of changes over the last year, two years, and so it would be helpful to understand how that might trend.
Sure. So, as noted, there's no more assistance programs reducing any costs. So, those costs are reasonable to project forward with inflationary type increases, of course. And depending on, I know we are planning to attend, you know, further trade shows such as NAB that, you know, may have small spikes in costs, but not to as much of a significant event.
At the trade shows, Rob, it's in a smaller capacity than pre-COVID.
Okay. So we shouldn't expect a bump in April from NAB this year, or IBC, I guess, later in the year.
We will have a presence there, a strong presence, but it won't be to the same extent in terms of the number of staff that we have on site, and nor will there be as many international travelers coming in as well, too.
Got it. Okay. Thanks. Appreciate the answers.
And as a reminder, if you would like to signal with questions, please press star 1, your touchtone telephone. Again, star 1. Our next question will come from Stephen Lee with Raymond James.
Hey, guys. I may have missed this, but you average about $40 million in revenues a month in the quarter. In terms of 25, any dynamic to call out there?
Stephen, we routinely have, you know, ups and downs, bumpiness in terms of the revenues and deliveries. So, you know, there's nothing unusual about a 25 million, you know, shipments in February. And, yes, we did have, you know, very strong, you know, monthly shipments in the prior quarter. But we're sitting on Again, to our record high backlog of $176 million. So we will be delivering that over the next quarters. Of that $176 million, there is a component that is delivered outside of 12 months. And going forward, that number is in around the 10% range of the backlog.
Got it. And Brian, so given the backlog, so fully expect to get back to 40 in March and April?
Our deliveries, the revenue and deliveries are very dependent on our site access and our customers' readiness to be able to take shipments of the orders that they've taken. So they're you know, we're not in a position to give you a forecast for Q4. We do have a very significant backlog, and we'll do our utmost to deliver, you know, as much of it. But it is, you know, sequenced by the customer's availability, their readiness to take those solutions as well, too. So some of it is scheduled in the subsequent quarter and others in – fiscal 2023 as well too, but only about 10% of it would be delivered or scheduled for delivery outside of 12 months.
Got it. Thanks for the call, Brian.
You're welcome.
And that does conclude the question and answer session. I'll now turn the conference back over to you for any additional or closing remarks.
Thank you, Justin. I'd also like to thank our participants for their time and their questions and reiterate that we're very pleased with the company's strong performance during the third quarter, which saw quarterly sales of $120.6 million, Solid gross margins of 57.4 in the quarter yielding net earnings of 28 cents per share. We're entering the fourth quarter of fiscal 2022 with significant momentum fueled by a record high purchase order backlog, which combined with February shipments totals in excess of $201 million. Also fueled by the growing adoption and Successful large-scale deployments of E-WRIT's IP-based software-defined video networking solutions, or cloud solutions, by some of the largest broadcast new media and service providers in the industry, and also fueled by the growing adoption and successful large-scale deployments. With E-WRIT's significant investment in our software-defined IP IT services, and cloud technologies, the over 500 industry-leading IP SDN deployments, and the capabilities of our staff, Everts is poised to build upon our leadership position. Thank you, everyone, and good night.
Thank you. And that does conclude today's conference. We do thank you for your participation. Have an excellent day.
